CDC outlines new procedures for sepsis response; mask mandates resurface during COVID-19 increase; a recent study shows that technology can help support public health programs.
CDC Sets New Sepsis Hospital Standards
The CDC on Thursday announced new guidelines to assist hospitals in the detection and treatment of cases of sepsis faster, according to The New York Times. The procedures, consisting of a 35-page document outlining the “core elements” of a hospital sepsis program, is designed to help administrators gather experts from various medical backgrounds to identify and treat sepsis faster. Raymond Dantes, MD, a CDC medical advisor and one of the specialists who designed the new strategies said they were planned to “complement clinical guidelines.” Sepsis is a factor in 1.7 million hospitalizations in the country each year.
Mask Mandates Resurface
The latest uptick in COVID-19 cases in some areas has incited a handful of organizations around the country to reinstate mask mandates, reviving the debate over where masking mandates fit into an era of living with COVID-19, reported The Hill. Lionsgate movie studio requested that its employees wear masks on certain floors after a few staff members tested positive for COVID-19, and Kaiser Permanente started to require staff, patients, and visitors wear masks at its Santa Rosa, California, facility. Hospitalizations because of COVID-19 have been increasing in the past few weeks, but CDC data shows that hospital admission rates are still determined to be low in 97% of the United States.
Technology Supports Public Health Programs
A program called the SCALE-UP Counts program was created to promote COVID-19 testing through collaboration with local schools, particularly those that serve historically marginalized populations, according to a press release from the University of Utah Huntsman Cancer Institute. This was carried out through 2-way texting, meaning that staff, parents, or guardians could respond. SCALE-Up Counts aimed to make it easier for schools to have access to COVID-19 testing and gave direction to families and staff on when to test. Four months after the program’s initiation, 19% of the K-12 school staff engaged with the SCALE-UP Counts system in some way. These results illustrate that the program helped schools and families traverse the pandemic and can also help researchers understand how to grow participation in future initiatives like cancer prevention, screening, and education in the future.
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
AA Unlikely to Cause Anxiety, Depression but May Be Affected by Mental Illness
May 7th 2024A Mendelian randomization study using genetic analysis found that alopecia areata (AA) increases the risk of anxiety and depression, but not the other way around, providing unique evidence for a causal link while adding to existing evidence.
Read More